Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / BIOTECH ETF
-
Number of holders
-
81
-
Total 13F shares, excl. options
-
1,758,327
-
Shares change
-
-18,040
-
Total reported value, excl. options
-
$220,890,303
-
Value change
-
-$1,567,342
-
Put/Call ratio
-
27.3%
-
Number of buys
-
30
-
Number of sells
-
-36
-
Price
-
$125.63
Significant Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) as of Q2 2017
93 filings reported holding BBH - VANECK ETF TRUST - BIOTECH ETF as of Q2 2017.
VANECK ETF TRUST - BIOTECH ETF (BBH) has 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,758,327 shares
.
Largest 10 shareholders include ALLIANCEBERNSTEIN L.P. (1,032,829 shares), MORGAN STANLEY (87,724 shares), UBS Group AG (74,067 shares), ROYAL BANK OF CANADA (60,547 shares), MURPHY CAPITAL MANAGEMENT INC (47,913 shares), Endurant Capital Management LP (45,999 shares), Strategic Financial Services, Inc, (26,972 shares), BOSTON RESEARCH & MANAGEMENT INC (21,908 shares), Cambridge Investment Research Advisors, Inc. (21,573 shares), and ASPIRIANT, LLC (19,508 shares).
This table shows the top 81 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.